June 20, 2007 NASD OTC-BB: MRDAF

www.streetinvesting.com: Meridian Co. Ltd. vs. Current Events

Jun 20, 2007 (M2 PRESSWIRE via COMTEX News Network) -- Please visit www.Streetinvesting.com for the full report, additional research and related articles on the company mentioned herein.

Wall Street treaded softly at the Bell this Tuesday as the Real Estate sector disclosed a declining economic diagnosis. Reports from the National Association of Homebuilders defined the official figures on the drop of new homes and apartments construction as 2.1 % for May. Investors were very well aware that this sector was in jeopardy, but now that the statistics are out they might look at it as a portent of the economy's well-being. Old fears might hinder the bashful bull response which has recently overruled the dominant bearish trend directing the market the last few weeks. Investor's sentiment is still quite raw about the different factors skulking the economy, namely inflation, interest rate and today's economic data on the housing sector. This week trading sessions is set to look more like a test of faith more than anything. Meridian Co. Ltd. (OTCBB: MRDAF) closed down at $ 0.74 with a trading volume of 11,520 this Tuesday.

Our research team has been walking the mile, investigating the possibilities floating about in the Over-the-Counter Bulletin Board. As the market spins more spice and thorn everyday, pulling investors back to the learning bench, we have brought forward the following contender, Meridian Co. Ltd. ("Meridian" or the "Company").

In a press release announcement made on Tuesday 19th June, 2007, Meridian Co. Ltd., an industry leader in the research, development, manufacturing and sales of advanced medical equipment, was thrilled to have Dr. Lionel Bissoon, a prominent celebrity weight-loss doctor, contract with the company to become the exclusive medical endorser for the LAPEX 2000 LipoLaser. This innovative new medical device is currently pending an FDA 510(k) clearance in the United States.

Dr. Bissoon is the leading authority in the U.S.A. on Mesotherapy (medical specialty focusing on promoting weight loss and eliminating cellulite) with practices in New York and Palm Beach. Dr. Bissoon is the best selling author of The Cellulite Cure and has been featured in numerous print and broadcast stories including appearances on ABC's "20/20", The Rachael Ray Show, CBS's "48 Hours", Vogue, People, and the New York Times.

Dr. Bissoon will work with Meridian regarding potential speaking or representation engagements at trade shows or medical conferences where he will discuss product information pertaining to the LAPEX 2000 LipoLaser. Dr. Bissoon is very excited about this new technology and commented, "The LAPEX 2000 LipoLaser holds the potential to revolutionize the aesthetic market for the reduction of cellulite and will offer clients a fantastic new non-invasive alternative to help them meet their goals."

The LAPEX 2000 LipoLaser was designed to target the medical and aesthetic market, specifically to address body shaping/contouring, spot fat reduction, and reduction in the appearance of cellulite. The LAPEX 2000 LipoLaser's non-invasive treatment is considered one of the most innovative methods to treat those stubborn areas of fat that do not respond to diet and exercise. The demand for this type of treatment is expected to grow rapidly, not only in the plastic surgery profession but in any clinical setting such as medi-spas and wellness centers that treat localized body fat deposits which may not have responded to diet and exercise.

Meridian is an established leader in the research/development, manufacturing and sales of advanced medical devices in the healthcare industry. With a dynamic research and development team, Meridian is at the forefront in the development of cutting edge medical technologies. The Company presently holds a total of 18 worldwide patents on its technology, and has received FDA approval and Health Canada approval as well as other international regulatory approvals, for many of its products. Meridian has over 1500 clients including physicians, hospitals, clinics, healthcare professionals, and wellness centers in Korea, USA, Canada, China, Japan and Europe, and continues to successfully market its superior product line to a growing number of clients worldwide.

Having to deal with the poorest performance of the Real Estate sector since last January's 13.9% decline, The Street would have to keep a candle of hope so as not to be bruised by the bears' impulse yet again. Meridian Co. Ltd. will without doubt have much to offer in terms of news release and development, and we will have a sentry ready to send you the alarm as they sprout out to the public. Please visit streetinvesting.com as we bring more content regarding Meridian found exclusively on our website.

Please visit www.streetinvesting.com for a complimentary subscription to access this issuance and other related in-depth articles. Please note that membership does not require credit card information nor does it require a commitment to our service.

We have initiated this news release as a tool to keep investors informed about the market. The information contained herein comes from an unbiased perspective and we do not have a vested interest in the companies mentioned in this release. Becoming a member to www.streetinvesting.com will give you access to all the on-going information and investment news that we come across.

Investors wishing to seek a different approach to their investment theories and concepts and to be informed of unique investment opportunities should also visit www.streetinvesting.com for a free membership.

About Street Investing

Streetinvesting.com has now become a leading online financial newsletter community with thousands of investors from around the world. Our goal is to bring our theories and techniques to investors seeking a different and unique approach to investment ideas. We have a research team that has been built upon the premise of finding companies that we feel may interest investors looking for that unique and tactical edge. More information can be found on our website at www.streetinvesting.com

If you have been brought here under false pretense, please let our staff know by emailing us at [email protected]. Please feel free to visit our site for more information and a free membership.

This news release shall not constitute an offer to sell or the solicitation of any offer to buy securities in any jurisdiction.

All material herein was prepared by Streetinvesting.com (Street Investing) based upon information believed to be reliable. The information contained herein is not guaranteed by Streetinvesting.com to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Streetinvesting.com is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. Streetinvesting.com may receive compensation in cash or shares from independent third parties or from the companies mentioned.

Streetinvesting.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.

You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and Streetinvesting.com undertakes no obligation to update such statements.

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to [email protected].